Comparative study between different methods for treatment of recurrent anterior idiopathic epistaxis in children: a

A M Abdelghany1, A A A Hendy2, A F Allam3

  • 1Otorhinolaryngology Department, Benha University, Benha, Egypt.

Rhinology
|January 5, 2026
PubMed

Insights

Antiseptic plus corticosteroid cream offers the most durable relief for children

Area of Science:

  • Otolaryngology
  • Pediatric Medicine
  • Dermatology

Background:

  • Recurrent idiopathic anterior epistaxis is a common pediatric condition with debated management strategies.
  • Optimal treatment for pediatric epistaxis requires evaluation of various therapeutic options.
  • This study addresses the need for evidence-based guidelines in managing childhood nosebleeds.

Purpose of the Study:

  • To compare the efficacy of antiseptic cream, antiseptic plus corticosteroid cream, and silver nitrate cautery.
  • To evaluate the reduction in epistaxis severity using the Epistaxis Severity Score (ESS).
  • To determine the most effective treatment for recurrent idiopathic anterior epistaxis in children.

Main Methods:

  • A prospective randomized dual-centre clinical trial involving 136 children.
  • Participants were allocated to antiseptic cream, antiseptic plus corticosteroid cream, or silver nitrate cautery.
  • Epistaxis Severity Score (ESS) was measured at baseline and at 2 weeks, 1, 3, and 6 months post-intervention.

Main Results:

  • All treatment groups demonstrated significant reductions in Epistaxis Severity Score (ESS) over time.
  • Silver nitrate cautery provided the quickest initial improvement at 2 weeks.
  • Antiseptic plus corticosteroid cream showed the most substantial and sustained improvement from 1 month to 6 months.

Conclusions:

  • While silver nitrate cautery offers rapid short-term epistaxis control, antiseptic plus corticosteroid cream yields the most durable long-term improvement.
  • A short, two-week course of antiseptic plus corticosteroid cream is effective.
  • This combination therapy should be considered a primary treatment option for recurrent idiopathic anterior epistaxis in pediatric patients.
Abstract